A retrospective cohort investigation of seroprevalence of Marburg virus and ebolaviruses in two different ecological zones in Uganda
暂无分享,去创建一个
L. Nyakarahuka | P. Rollin | S. Nichol | B. Knust | Ilana J. Schafer | J. Lutwama | S. Balinandi | Sophia Mulei | A. Tumusiime | Jackson Kyondo | T. Shoemaker | I. Schafer | Alex Tumusiime
[1] A. Schuh,et al. Egyptian rousette bats maintain long-term protective immunity against Marburg virus infection despite diminished antibody levels , 2017, Scientific Reports.
[2] F. Checchi,et al. Asymptomatic infection and unrecognised Ebola virus disease in Ebola-affected households in Sierra Leone: a cross-sectional study using a new non-invasive assay for antibodies to Ebola virus. , 2017, The Lancet. Infectious diseases.
[3] J. Glynn,et al. A systematic review and meta-analysis of seroprevalence surveys of ebolavirus infection , 2017, Scientific Data.
[4] L. Nyakarahuka,et al. How severe and prevalent are Ebola and Marburg viruses? A systematic review and meta-analysis of the case fatality rates and seroprevalence , 2016, BMC Infectious Diseases.
[5] Sarah L. Keasey,et al. Human Survivors of Disease Outbreaks Caused by Ebola or Marburg Virus Exhibit Cross-Reactive and Long-Lived Antibody Responses , 2016, Clinical and Vaccine Immunology.
[6] L. Hooper,et al. Risk factors for transmission of Ebola or Marburg virus disease: a systematic review and meta-analysis , 2015, International journal of epidemiology.
[7] A. Mbonye,et al. Multidistrict Outbreak of Marburg Virus Disease-Uganda, 2012. , 2015, The Journal of infectious diseases.
[8] W. Team. Ebola Virus Disease in West Africa — The First 9 Months of the Epidemic and Forward Projections , 2014 .
[9] A. Schuh,et al. Marburgvirus Resurgence in Kitaka Mine Bat Population after Extermination Attempts, Uganda , 2014, Emerging infectious diseases.
[10] Mikiko Senga,et al. Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections. , 2014, The New England journal of medicine.
[11] Timothy D. Flietstra,et al. Seasonal Pulses of Marburg Virus Circulation in Juvenile Rousettus aegyptiacus Bats Coincide with Periods of Increased Risk of Human Infection , 2012, PLoS pathogens.
[12] P. Formenty,et al. Outbreak of Marburg hemorrhagic fever among miners in Kamwenge and Ibanda Districts, Uganda, 2007. , 2011, The Journal of infectious diseases.
[13] N. Wauquier,et al. Risk factors for Zaire ebolavirus--specific IgG in rural Gabonese populations. , 2011, The Journal of infectious diseases.
[14] A. MacNeil,et al. Serologic Cross-Reactivity of Human IgM and IgG Antibodies to Five Species of Ebola Virus , 2011, PLoS neglected tropical diseases.
[15] N. Wauquier,et al. High Prevalence of Both Humoral and Cellular Immunity to Zaire ebolavirus among Rural Populations in Gabon , 2010, PloS one.
[16] Alan Kemp,et al. Isolation of Genetically Diverse Marburg Viruses from Egyptian Fruit Bats , 2009, PLoS pathogens.
[17] A. Viera. Odds ratios and risk ratios: what's the difference and why does it matter? , 2008, Southern medical journal.
[18] S. Lahm,et al. Morbidity and mortality of wild animals in relation to outbreaks of Ebola haemorrhagic fever in Gabon, 1994-2003. , 2007, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[19] R. Hatchett,et al. Low seroprevalence of IgG antibodies to Ebola virus in an epidemic zone: Ogooué-Ivindo region, Northeastern Gabon, 1997. , 2005, The Journal of infectious diseases.
[20] J. Gonzalez,et al. Ebola Virus Antibody Prevalence in Dogs and Human Risk , 2005, Emerging infectious diseases.
[21] H. Feldmann,et al. Evidence for occurrence of filovirus antibodies in humans and imported monkeys: do subclinical filovirus infections occur worldwide? , 1992, Medical Microbiology and Immunology.
[22] C. Roth,et al. Risk Factors for Marburg Hemorrhagic Fever, Democratic Republic of the Congo , 2003, Emerging infectious diseases.
[23] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[24] J. Gonzalez,et al. Ebola and Marburg virus antibody prevalence in selected populations of the Central African Republic. , 2000, Microbes and infection.
[25] M. Georges-Courbot,et al. Leptospirosis and Ebola virus infection in five gold-panning villages in northeastern Gabon. , 1999, The American journal of tropical medicine and hygiene.
[26] P. Jahrling,et al. ELISA for the detection of antibodies to Ebola viruses. , 1999, The Journal of infectious diseases.
[27] H. Feldmann,et al. Prevalence of IgG antibodies to Ebola virus in individuals during an Ebola outbreak, Democratic Republic of the Congo, 1995. , 1999, The Journal of infectious diseases.
[28] M. Georges-Courbot,et al. Ebola hemorrhagic fever outbreaks in Gabon, 1994-1997: epidemiologic and health control issues. , 1999, The Journal of infectious diseases.
[29] J. Gonzalez,et al. Filovirus activity among selected ethnic groups inhabiting the tropical forest of equatorial Africa. , 1993, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[30] J. Gonzalez,et al. Haemorrhagic fever virus activity in equatorial Africa: distribution and prevalence of filovirus reactive antibody in the Central African Republic. , 1993, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[31] S. Bennett,et al. A simplified general method for cluster-sample surveys of health in developing countries. , 1991, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.
[32] D. Fontenille,et al. Antibodies to haemorrhagic fever viruses in Madagascar populations. , 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[33] J. Gonzalez,et al. Antibody prevalence against haemorrhagic fever viruses in randomized representative Central African populations. , 1989, Research in virology.
[34] J. McCormick,et al. Viral hemorrhagic fever antibodies in Nigerian populations. , 1988, The American journal of tropical medicine and hygiene.
[35] H. Fleury,et al. [Serological study of the virus responsible for hemorrhagic fever in an urban population of Cameroon]. , 1988, Bulletin de la Societe de pathologie exotique et de ses filiales.
[36] M. Georges-Courbot,et al. [Current serologic data on viral hemorrhagic fevers in the Central African Republic]. , 1987, Bulletin de la Societe de pathologie exotique et de ses filiales.
[37] D. Gajdusek,et al. Hemorrhagic fever virus infections in an isolated rainforest area of central Liberia. Limitations of the indirect immunofluorescence slide test for antibody screening in Africa. , 1986, Tropical and geographical medicine.
[38] P. Bourée,et al. Ebola virus infection in man: a serological and epidemiological survey in the Cameroons. , 1983, The American journal of tropical medicine and hygiene.
[39] J. McCormick,et al. Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. , 1983, Bulletin of the World Health Organization.
[40] P. Tukei,et al. Antibodies against haemorrhagic fever viruses in Kenya populations. , 1983, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[41] D. Heymann,et al. Ebola hemorrhagic fever: Tandala, Zaire, 1977-1978. , 1980, The Journal of infectious diseases.
[42] G. van der Groen,et al. Measurement of antibodies to Ebola virus in human sera from N. W.-Zaire. , 1979, Annales de la Societe belge de medecine tropicale.